IL260979A - - Google Patents
Info
- Publication number
- IL260979A IL260979A IL26097918A IL26097918A IL260979A IL 260979 A IL260979 A IL 260979A IL 26097918 A IL26097918 A IL 26097918A IL 26097918 A IL26097918 A IL 26097918A IL 260979 A IL260979 A IL 260979A
- Authority
- IL
- Israel
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/04—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from germ cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662292014P | 2016-02-05 | 2016-02-05 | |
| US201662299361P | 2016-02-24 | 2016-02-24 | |
| US201662350032P | 2016-06-15 | 2016-06-15 | |
| PCT/US2017/016723 WO2017136834A1 (en) | 2016-02-05 | 2017-02-06 | Methods of differentiating stem cell-derived ectodermal lineage precursors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL260979A true IL260979A (cg-RX-API-DMAC7.html) | 2018-09-20 |
| IL260979B1 IL260979B1 (en) | 2023-04-01 |
| IL260979B2 IL260979B2 (en) | 2023-08-01 |
Family
ID=59500066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL260979A IL260979B2 (en) | 2016-02-05 | 2018-08-05 | Methods for the differentiation of stem cells into ectodermal precursor cell lines |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11326148B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3411048A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7523885B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180105236A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017214749B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3013623A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL260979B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017136834A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7523885B2 (ja) | 2016-02-05 | 2024-07-29 | メモリアル スローン ケタリング キャンサー センター | 幹細胞由来外胚葉系統前駆体を分化する方法 |
| US10815287B2 (en) * | 2016-08-02 | 2020-10-27 | Jiangsu Hengrui Medicine Co., Ltd. | Acylated derivative of human insulin or analogue thereof |
| CA3075036A1 (en) * | 2017-09-07 | 2019-03-14 | Memorial Sloan-Kettering Cancer Center | Methods of differentiating stem cell-derived ectodermal lineage precursors |
| JP2021502091A (ja) * | 2017-11-10 | 2021-01-28 | メモリアル スローン ケタリング キャンサー センター | 幹細胞からの成長ホルモン産生細胞の誘導およびその使用 |
| IT201800009133A1 (it) * | 2018-10-03 | 2020-04-03 | Università Cattolica del Sacro Cuore | Identificazione di biomarcatori molecolari predittivi di risposta al trattamento radiochemoterapico nel carcinoma della cervice |
| KR102451074B1 (ko) * | 2019-01-11 | 2022-10-05 | 차의과학대학교 산학협력단 | Tgf-베타 ⅰ 수용체의 저해제 및 bmp 저해제를 포함하는 줄기 세포의 신경능선세포로의 분화용 조성물, 키트, 및 이를 이용한 방법 |
| KR20200087541A (ko) * | 2019-01-11 | 2020-07-21 | 차의과학대학교 산학협력단 | Tgf-베타 ⅰ 수용체의 저해제 및 bmp 저해제를 포함하는 줄기 세포의 신경능선세포로의 분화용 조성물, 키트, 및 이를 이용한 방법 |
| WO2025085899A1 (en) * | 2023-10-19 | 2025-04-24 | The Research Foundation For The State University Of New York | Production of salivary gland epithelial progenitors and salivary gland cell organoids for regenerative medicine and drug testing purposes |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20135796B (en) | 2006-03-07 | 2013-04-10 | Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation | |
| US8535719B2 (en) | 2006-07-07 | 2013-09-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Biohybrid elastomeric scaffolds and methods of use thereof |
| US8642334B2 (en) | 2009-02-17 | 2014-02-04 | Memorial Sloan Kettering Cancer Center | Methods of neural conversion of human embryonic stem cells |
| EP2464723B1 (en) | 2009-08-12 | 2016-06-22 | Kyoto University | Method for inducing differentiation of pluripotent stem cells into neural precursor cells |
| ES2747803T3 (es) | 2010-05-25 | 2020-03-11 | Memorial Sloan Kettering Cancer Center | Método de diferenciación a nociceptores de células madre embrionarias humanas y sus usos |
| US20110296542A1 (en) | 2010-05-28 | 2011-12-01 | Kevin Ka-Wang Wang | Exogenous matrix-supported topical application of stem cells to organ surface |
| EP2658966B1 (en) | 2010-12-31 | 2017-04-05 | University of Georgia Research Foundation, Inc. | Differentiation of human pluripotent stem cells to multipotent neural crest cells |
| EP2667881A4 (en) * | 2011-01-24 | 2015-04-22 | Univ Leland Stanford Junior | METHOD FOR IN VITRO GENERATION OF INTERNAL CELLS |
| AU2012332269B2 (en) * | 2011-11-04 | 2018-05-31 | Memorial Sloan-Kettering Cancer Center | Midbrain dopamine (DA) neurons for engraftment |
| WO2013166488A1 (en) * | 2012-05-04 | 2013-11-07 | Indiana University Research & Technology Corporation | Methods for generating the inner ear and other cranial placode-derived tissues using pluripotent stem cells |
| WO2013188744A1 (en) | 2012-06-15 | 2013-12-19 | Baylor College Of Medicine | Perineurium derived adult stem cells and methods of use |
| US10160950B2 (en) * | 2013-03-01 | 2018-12-25 | Wisconsin Alumni Research Foundation | Methods of maintaining, expanding and differentiating neuronal subtype specific progenitors |
| JP6756610B2 (ja) | 2013-04-26 | 2020-09-16 | メモリアル スローン ケタリング キャンサー センター | 多分化能細胞および多能性細胞の分化を方向付けることによって発生させる皮質介在ニューロンおよびその他のニューロン細胞 |
| EP3071685B1 (en) * | 2013-11-21 | 2026-07-29 | Memorial Sloan-Kettering Cancer Center | Specification of functional cranial placode derivatives from human pluripotent stem cells |
| JP6304818B2 (ja) | 2014-04-21 | 2018-04-04 | 花王株式会社 | 皮膚由来多能性前駆細胞の作製方法 |
| JP6598185B2 (ja) | 2014-11-07 | 2019-10-30 | 国立大学法人京都大学 | 軟骨過形成疾患の予防および治療剤ならびにそのスクリーニング方法 |
| WO2016104574A1 (ja) | 2014-12-24 | 2016-06-30 | 国立大学法人京都大学 | 異所性骨化の予防・治療剤及びそのスクリーニング方法 |
| WO2016196661A1 (en) * | 2015-06-01 | 2016-12-08 | Memorial Sloan-Kettering Cancer Center | Methods of in vitro differentiation of midbrain dopamine (mda) neurons |
| JP6593811B2 (ja) | 2015-06-02 | 2019-10-23 | 国立研究開発法人産業技術総合研究所 | 神経堤細胞から自律神経系の細胞への分化誘導方法 |
| CN108291197B (zh) * | 2015-10-21 | 2022-09-16 | 印第安纳大学研究与技术公司 | 生成人内耳感觉上皮和感觉神经元的方法 |
| WO2017112901A1 (en) * | 2015-12-23 | 2017-06-29 | Memorial Sloan-Kettering Cancer Center | Cell-based treatment and drug discovery in hirschsprung's disease enabled by pluripotent stem cell-derived human enteric neural crest lineages |
| EP3448985A4 (en) * | 2016-01-27 | 2019-08-21 | Memorial Sloan-Kettering Cancer Center | DIFFERENTIATION OF CORTIC NEURONS FROM HUMAN PLURIPOTENTIAL STEM CELLS |
| JP7523885B2 (ja) | 2016-02-05 | 2024-07-29 | メモリアル スローン ケタリング キャンサー センター | 幹細胞由来外胚葉系統前駆体を分化する方法 |
-
2017
- 2017-02-06 JP JP2018540792A patent/JP7523885B2/ja active Active
- 2017-02-06 CA CA3013623A patent/CA3013623A1/en active Pending
- 2017-02-06 AU AU2017214749A patent/AU2017214749B2/en active Active
- 2017-02-06 KR KR1020187025604A patent/KR20180105236A/ko not_active Withdrawn
- 2017-02-06 WO PCT/US2017/016723 patent/WO2017136834A1/en not_active Ceased
- 2017-02-06 EP EP17748353.4A patent/EP3411048A4/en active Pending
-
2018
- 2018-08-03 US US16/054,071 patent/US11326148B2/en active Active
- 2018-08-05 IL IL260979A patent/IL260979B2/en unknown
-
2022
- 2022-04-04 US US17/712,785 patent/US11959104B2/en active Active
- 2022-04-11 JP JP2022065090A patent/JP2022088676A/ja active Pending
-
2024
- 2024-03-15 US US18/606,805 patent/US20240327796A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20220228123A1 (en) | 2022-07-21 |
| EP3411048A1 (en) | 2018-12-12 |
| US11959104B2 (en) | 2024-04-16 |
| IL260979B1 (en) | 2023-04-01 |
| IL260979B2 (en) | 2023-08-01 |
| JP2019503703A (ja) | 2019-02-14 |
| US11326148B2 (en) | 2022-05-10 |
| AU2017214749A8 (en) | 2018-09-13 |
| EP3411048A4 (en) | 2019-07-31 |
| WO2017136834A1 (en) | 2017-08-10 |
| CA3013623A1 (en) | 2017-08-10 |
| US20190071643A1 (en) | 2019-03-07 |
| AU2017214749A1 (en) | 2018-09-06 |
| AU2017214749B2 (en) | 2024-03-28 |
| WO2017136834A8 (en) | 2018-08-23 |
| KR20180105236A (ko) | 2018-09-27 |
| JP2022088676A (ja) | 2022-06-14 |
| US20240327796A1 (en) | 2024-10-03 |
| JP7523885B2 (ja) | 2024-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019002665A2 (cg-RX-API-DMAC7.html) | ||
| BR112018004986A2 (cg-RX-API-DMAC7.html) | ||
| BR112019001429A2 (cg-RX-API-DMAC7.html) | ||
| BR202017015425U2 (cg-RX-API-DMAC7.html) | ||
| BR212018070320U2 (cg-RX-API-DMAC7.html) | ||
| BR112019011044B1 (pt) | Compostos de pirazol substituído, seu uso, e composição farmacêutica | |
| BR112019008501B1 (pt) | Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador | |
| BR112019003116B1 (pt) | Configuração de símbolo de rajada comum de uplink | |
| BR112019000061B1 (pt) | Comutação e modulação de splicing de pré-mrna compreendendo porções de arcabouço bicíclico, com características melhoradas para o tratamento de distúrbios genéticos | |
| BR112018076493B1 (pt) | Sistemas e métodos para detecção de posição de feixe de luz | |
| BR112018073794B1 (pt) | Partícula, método de geração da partícula, vacina ou composição farmacêutica | |
| BR122026002520A2 (pt) | Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno | |
| BR112018070934B1 (pt) | Polipeptídeo ligante de icos (icosl) variante, proteína de fusão, conjugado, método para engenharia de uma célula, agente infeccioso, composição farmacêutica e uso da mesma | |
| BR112019006736A2 (cg-RX-API-DMAC7.html) | ||
| CN303635691S (zh) | 多功能暗装入墙盒 | |
| CN303596279S (zh) | 汽车内饰面板(主纹理-雪乡) | |
| CN303628118S (zh) | 收银支付一体化终端 | |
| CN303596938S (zh) | 高压清洗机(apw-vao) | |
| CN303537476S (zh) | 飞碟吊椅 | |
| CN303606495S (zh) | 即热水龙头(a) | |
| CN303536045S (zh) | 嫁衣(15) | |
| CN303537535S (zh) | 车家床(四六分圆拉床半围) | |
| CN303545385S (zh) | 壁挂式管线机(lb-a000g05) | |
| CN303536111S (zh) | 眼罩(条纹) | |
| CN303536110S (zh) | 眼罩(花纹) |